Real-World Therapeutic Outcomes of S-1 Adjuvant Chemotherapy for pStage II/III Gastric Cancer in the Elderly
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Real-World Therapeutic Outcomes of S-1 Adjuvant Chemotherapy for pStage II/III Gastric Cancer in the Elderly ; volume:62 ; number:1 ; year:2021 ; pages:40-52 ; extent:13
European surgical research ; 62, Heft 1 (2021), 40-52 (gesamt 13)
- Creator
-
Kunisaki, Chikara
Sato, Sho
Tsuchiya, Nobuhiro
Kubo, Hirokazu
Watanabe, Jun
Sato, Tsutomu
Takeda, Kazuhisa
Tamura, Yuko
Kasahara, Kohei
Kosaka, Takashi
Akiyama, Hirotoshi
Endo, Itaru
- DOI
-
10.1159/000515175
- URN
-
urn:nbn:de:101:1-2021052700204573245686
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kunisaki, Chikara
- Sato, Sho
- Tsuchiya, Nobuhiro
- Kubo, Hirokazu
- Watanabe, Jun
- Sato, Tsutomu
- Takeda, Kazuhisa
- Tamura, Yuko
- Kasahara, Kohei
- Kosaka, Takashi
- Akiyama, Hirotoshi
- Endo, Itaru
Other Objects (12)
Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial
Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer
Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
The efficacy of adjuvant chemotherapy for older adults with stage II/III gastric cancer: a retrospective cohort study
Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
Nutritional Status Indicators Predict Tolerability to Adjuvant Chemotherapy in Patients with Stage II/III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
Correction to: Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
N0 colorectal cancer in the elderly: prognostic role of advanced age and correlation with adjuvant chemotherapy
Real-world analysis of survival benefit of surgery and adjuvant therapy in elderly patients with colorectal cancer
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial
Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer
Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
The efficacy of adjuvant chemotherapy for older adults with stage II/III gastric cancer: a retrospective cohort study
Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
Nutritional Status Indicators Predict Tolerability to Adjuvant Chemotherapy in Patients with Stage II/III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
Correction to: Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
N0 colorectal cancer in the elderly: prognostic role of advanced age and correlation with adjuvant chemotherapy
Real-world analysis of survival benefit of surgery and adjuvant therapy in elderly patients with colorectal cancer
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial
Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer
Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
The efficacy of adjuvant chemotherapy for older adults with stage II/III gastric cancer: a retrospective cohort study
Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
Nutritional Status Indicators Predict Tolerability to Adjuvant Chemotherapy in Patients with Stage II/III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
Correction to: Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
N0 colorectal cancer in the elderly: prognostic role of advanced age and correlation with adjuvant chemotherapy
Real-world analysis of survival benefit of surgery and adjuvant therapy in elderly patients with colorectal cancer
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)